Company news

Crescita Therapeutics, Inc. news in 2018

Crescita Therapeutics, Inc.'s news releases, calls and decks from 2018, newest first.

View company

U.S. FDA Approves Removal of "Not for Home Use" Label Restriction for Pliaglis®

December 17, 2018

Crescita Therapeutics(TM) Reports 2018 Third Quarter Results Strong Royalty Revenue and Achievement of First Pliaglis US Sales Milestone Positive Adjusted EBITDA of $0.8M

November 9, 2018

Crescita Reinvigorates Skincare Line Leveraging its MMPE(TM) Technology and Becomes One of the First Companies Worldwide to Release Anti-Ageing Formulation Using ECOBIOTYS®

November 8, 2018

Crescita's Patented Delivery Technologies Demonstrate Enhanced Skin Permeation of Cannabidiol

October 15, 2018

Crescita Therapeutics(TM) Reports 2018 Second Quarter Results

August 10, 2018

Crescita Therapeutics Inc. to Present at The MicroCap Conference on June 21st in Toronto

June 19, 2018

Crescita Therapeutics(TM) Announces Director Election Results of its Annual General Meeting

June 13, 2018

Crescita Therapeutics(TM) Reports 2018 First Quarter Results

May 9, 2018

Crescita Therapeutics(TM) To Present at the 2018 Bloom Burton &Co. Healthcare Investor Conference in Toronto

April 26, 2018

Crescita Therapeutics Inc. Adds Recognized Skincare Expert to its Leadership Team

April 5, 2018

Crescita Therapeutics(TM) Announces the Appointment of Serge Verreault as President & CEO

April 3, 2018

Crescita Announces Launch of Pliaglis in U.S.

March 29, 2018

Crescita Therapeutics(TM) Reports 2017 Fourth Quarter and Year End Results

March 28, 2018

Crescita Therapeutics Inc. Announces Completion of Oversubscribed Rights Offering

March 12, 2018

Crescita Therapeutics Inc. Announces Rights Offering to Raise Up To $3.7 Million

January 31, 2018